[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338117-105":59,"doc-detail-338117-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","targeting-bmi1-for-enhancing-anoikis-sensitivity-and-inhibiting-metastasis-in-colorectal-cancer","Targeting Bmi1 for Enhancing Anoikis Sensitivity and Inhibiting Metastasis in Colorectal Cancer","","Advanced metastatic colorectal cancer (CRC) patients face poor outcomes, driven in part by anoikis resistance in circulating metastatic cells. The study investigates how Bmi1 and its downstream Bmi1-midkine (MDK) axis regulate CRC cell responses to anoikis and metastatic behavior. Using bulk flow cytometry, RT-qPCR, in vivo mouse and zebrafish models, and patient tissue analyses, results show Bmi1 overexpression associates with distant metastasis, while Bmi1 suppression reduces metastatic potential and increases anoikis-linked apoptosis. Combining Bmi1 inhibition with irinotecan further augments apoptotic detachment and synergizes with MDK.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/targeting-bmi1-for-enhancing-anoikis-sensitivity-and-inhibiting-metastasis-in-colorectal-cancer/338117/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/targeting-bmi1-for-enhancing-anoikis-sensitivity-and-inhibiting-metastasis-in-colorectal-cancer/338117.png","ImageObject",300,407,{"name":92,"@type":93},"Theodore","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does the study focus on in colorectal cancer?","Question",{"text":112,"@type":113},"The study targets advanced metastatic colorectal cancer where low survival is linked to anoikis resistance in metastatic cancer cells.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which experimental approaches are used to test the role of Bmi1?",{"text":117,"@type":113},"Bulk flow cytometry and RT-qPCR are used, alongside in vivo experiments in mice and zebrafish and analyses of patient tissues.",{"name":119,"@type":110,"acceptedAnswer":120},"What do the results show about Bmi1 and metastasis?",{"text":121,"@type":113},"Higher Bmi1 expression correlates with distant metastasis, and suppressing Bmi1 reduces CRC metastatic potential and increases apoptotic cells detached from the matrix.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},338117,1790159733,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},7971461740886,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","CANCER GENOMICS & PROTEOMICS 21: 523-532 (2024) doi:10.21873/cgp.20469  \nTargeting Bmi1 for Enhancing Anoikis Sensitivity and Inhibiting Metastasis in Colorectal Cancer  \nYIN-CHOU HSU 1,2,3,4,5 , CHI-WEN LUO6,7 , SHU-JYUAN CHANG 1 , CHIAO-YING LAI 1 , YU-TZU YANG 1 , YI-ZI CHEN 1 , WANG-TA LIU8 , CHUN-CHIEH WU9 , CHEUK-KWAN SUN5,10 , MING-FENG HOU 11\\# and MEI-REN PAN1,12,13\\#  \n1Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan, R.O.C.;  \n2Department of Emergency Medicine, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan, R. O. C. ;  \n3School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan, R. O. C. ;  \n4School of Chinese Medicine for Post Baccalaureate, I-Shou University, Kaohsiung, Taiwan, R. O. C. ;  \n5School of Medicine for International Student, I-Shou University, Kaohsiung, Taiwan, R. O. C. ;  \n6Division of Breast Oncology and Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, R.O.C.;  \n7Department of Cosmetic Science and Institute of Cosmetic Science, Chia Nan University of Pharmacy and Science, Tainan, Taiwan, R.O.C.;  \n8Department of Biotechnology, Kaohsiung Medical University, Kaohsiung, Taiwan, R. O. C. ;  \n9Department of Pathology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan, R.O.C.;  \n10Department of Emergency Medicine, E-Da Dachang Hospital, I-Shou University, Kaohsiung, Taiwan, R. O. C. ;  \n11Department of Biomedical Science and Environmental Biology, College of Life Science, Kaohsiung Medical University, Kaohsiung, Taiwan, R.O.C.;  \n12Drug Development and Value Creation Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan, R.O.C.;  \n13Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, R. O. C.  \nAbstract. Background/Aim: Patients diagnosed with advanced metastatic colorectal cancer (CRC) confront a bleak  \n\\# These Authors contributed equally to this work.  \nCorrespondence to: Mei-Ren Pan, Graduate Institute of Clinical Medicine, Kaohsiung Medical University, 100 Shin-Chuan 1st Road, Kaohsiung City 807, Taiwan, R.O.C. Tel: +886 73121101 ext 5092-34, Fax: +886 73218309, e-mail: [mrpan@cc.kmu.edu.tw](mrpan@cc.kmu.edu.tw) ; Ming-Feng Hou, Department of Biomedical Science and Environmental Biology, College of Life Science, Kaohsiung Medical University, 100 Shin-Chuan 1st Road, Kaohsiung City 807, Taiwan, R.O.C. Tel: +886 73121101 ext 6060, Fax: +886 73165011, [e-mail: mifeho@kmu.edu.tw](e-mail: mifeho@kmu.edu.tw)  \nKey Words: Colorectal cancers, Bmi1, anoikis resistance, metastasis, midkine.  \nThis article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license ([https://creativecommons.org/licenses/by-nc-nd/4.0](https://creativecommons.org/licenses/by-nc-nd/4.0)).  \nprognosis characterized by low survival rates. Anoikis, the programmed apoptosis resistance exhibited by metastatic cancer cells, is a crucial factor in this scenario. Materials and Methods: We employed bulk flow cytometry and RT-qPCRassays, conducted in vivo experiments with mice and zebrafish, and analyzed patient tissues to examine the effects of the B cell-specific Moloney murine leukemia virus insertion site 1 (Bmi1)-midkine (MDK) axis on the cellular response toanoikis. Bmi1 is pivotal in tumorigenesis. This study elucidated the involvement of Bmi1 in conferring anoikis resistance in CRC and explored its downstream targets associated with metastasis. Results: Elevated levels of Bmi1 expression correlated with distant metastasis in CRC. Suppression of Bmi1 significantly diminished the metastatic potential of CRC cells. Inhibition of Bmi1 led to an increase in the proportion of apoptotic SW620 cells detached from the matrix. This effect was further enhanced by the addition of irinotecan, a topoisomerase I inhibitor. Furthermore, Bmi1 was found t","cbCainGW56qCuqpY","https://ap.wps.com/l/cbCainGW56qCuqpY","pdf",5032146,"English","# Abstract\n## Background/Aim\n## Materials and Methods\n## Results\n## Conclusion\n# Introduction\n## Epidemiology and clinical burden\n## Metastasis and anoikis biology","[{\"question\":\"What problem does the study focus on in colorectal cancer?\",\"answer\":\"The study targets advanced metastatic colorectal cancer where low survival is linked to anoikis resistance in metastatic cancer cells.\"},{\"question\":\"Which experimental approaches are used to test the role of Bmi1?\",\"answer\":\"Bulk flow cytometry and RT-qPCR are used, alongside in vivo experiments in mice and zebrafish and analyses of patient tissues.\"},{\"question\":\"What do the results show about Bmi1 and metastasis?\",\"answer\":\"Higher Bmi1 expression correlates with distant metastasis, and suppressing Bmi1 reduces CRC metastatic potential and increases apoptotic cells detached from the matrix.\"}]","Targeting Bmi1 for Enhancing Anoikis Sensitivity and Inhibiting Metastasis in Colorectal Cancer | PDF",1790021999,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/aeef89f39e7fd353a7918b9cd1d06169.webp",983,1301,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8f80e5e348ea8c2ed3b2432bb0c229dc.webp",982,1299,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8497def3facbb566f9d578bfe0e8f4dc.webp",981,1298,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7a2185cbe1633bfc6c33c5d5c129a64e.webp",980,1297]